| Abbrv. | Definition |
| AAVs | Adeno-Associated Viruses |
| ADPKD | Autosomal Dominant Polycystic Kidney Disease |
| AMOs | anti-miRNA Oligonucleotides |
| ASGR | Asialoglycoprotein Receptor |
| ASOs | Antisense Oligonucleotides |
| AuNPs | Gold (Au) nanoparticles |
| Avs | Adenovirus |
| BBB | Blood-Brain-Barrier |
| BCL2 | B Cell lynphoma 2 |
| BIM | Bcl-2-like protein 11 |
| CIP | cyclin-dependent protein kinase |
| CLL | Chronic Lymphocytic Leukemia |
| c-MET | hepatocyte growth factor receptor |
| cSCC | cutaneus Squamous Cell Carcinoma |
| DENs | Dendrimer-Encapsulated Nanoparticles |
| DOTAP | 1,2-Dioleoyl-3-trimethylammonium propane |
| Dox | Doxorubicin |
| EMT | Epithelial-Mesenchymal Transition |
| ER-α | estrogen receptor-alfa |
| Evs | Extracellular Vesicles |
| FBGC | Foreign Body Giant Cells |
| FOXO3 | Forkhead box Other 3 |
| GalNac | N-Acetilgalattosammine |
| GD | Disialoganglioside |
| GMB | Glioblastoma Multiforme |
| HCC | Hepatocellular Carcinoma Cells |
| HGNPs | NIR responsive hollow gold nanoparticle |
| HmgA2 | High-mobility group AT-hook 2 |
| HNSCC | Head and Neck Squamous Cell Carcinoma |
| KIP1 | Kinesin-like protein 1 |
| Lac-GLN | Lactosylated Gramicidin-Containing Lipid Nanoparticles |
| LMWP | Low Molecular Weight Protamines |
| LNA | Locked Nucleic Acid |
| LPD | Liposome-Protamine-DNA |
| LPH | Liposome-Polycation-Hyaluronic acid |
| LVs | Lentivirus |
| miRNA | microRNA |
| MM | Multiple Myeloma |
| NIR | Near-Infrared-Radiation |
| NOD | Non-obese diabetic |
| NPs | Nanoparticles |
| NSCLC | Non-Small Cell Lung Cancer |
| PAMAM | Poly Amidoamine |
| PDCD4 | Programmed cell death protein 4 |
| PDGFRa | Platelet-derived growth factor receptor-a |
| PDGFRb | Platelet-derived growth factor receptor-b |
| PEG | Polyethylene Glycol |
| PEI | Polyethylenimine |
| pHLIP | pH-induced transmembrane structure |
| PLGA | Poly Lactic-co-Glycolic Acid |
| PNAs | Peptide Nucleic Acids |
| PSMA | Prostate-Specific Membrane Antigen |
| PTEN | Phosphatase and tensin homolog |
| RDG | Arg-Gly-Asp |
| RECK | Reversion-inducing-cysteine-rich protein with kazal motifs |
| RES | Reticuloendothelial System |
| RVG | Rabies Virus Glycoprotein |
| SAE | Severe Adverse Events |
| scFv | Single-chain antibody Fragment |
| SCID | Severe combined immunodeficiency |
| SELEX | Systematic Evolution of Ligands by EXponential enrichment |
| SNALPS | Stable-Nucleic-Acid-Lipid-Particles |
| sncRNA | small non-coding RNA |
| SPRY1 | Sprouty1 |
| ssDNA | single-stranded DNA |
| ssRNA | single-stranded RNA |
| TIMP3 | Metalloproteinase inhibitor 3 |
| TNBC | Triple-Negative Breast Cancer |
| TRAIL | TNF-related apoptosis-inducing ligand |
| UTRs | Untranslated Regions |
| VEGFR | Vascular Endothelial Growth Factor Receptor |
| ZEB1 | Zinc finger E-box-binding homeobox 1 |
| ZEB1 | Zinc finger E-box-binding homeobox 2 |